Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-04-19 @ 7:34 AM
Study NCT ID:
NCT00790933
Status:
COMPLETED
Last Update Posted:
2022-05-24
First Post:
2008-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
Sponsor:
Takeda
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C13008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None